Kym-001, a First-In-Class Oral Irak4 Protein Degrader, Induces Tumor Regression in Xenograft Models of Myd88-Mutant Abc DLBCL Alone and in Combination With BTK Inhibition

Hematological Oncology - United Kingdom
doi 10.1002/hon.89_2629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Combination of Irak4 (Ca-4948) and BTK (Vecabrutinib) Inhibitors Show Superior Efficacy in Preclinical Models of Abc DLBCL Tumors Containing Myd88 -L265p Mutations

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer

Cancer Letters
Cancer ResearchOncology
2014English

Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Activity of Oral Atovaquone Alone and in Combination With Antimony in Experimental Visceral Leishmaniasis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft Models

Clinical Cancer Research
Cancer ResearchOncology
2015English

Effect of Erythropoietin on Human Tumor Growth in Xenograft Models

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Coping With Unbalanced Class Data Sets in Oral Absorption Models

Journal of Chemical Information and Modeling
Computer Science ApplicationsChemistryChemical EngineeringLibraryInformation Sciences
2013English

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models

Clinical Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy